Medizinische Universität Graz - Research portal
Selected Publication:
SHR Neuro Cancer Cardio Lipid Metab Microb
Gattenloehner, S; Chuvpilo, S; Langebrake, C; Reinhardt, D; Muller-Hermelink, HK; Serfling, E; Vincent, A; Marx, A.
Novel RUNX1 isoforms determine the fate of acute myeloid leukemia cells by controlling CD56 expression.
Blood. 2007; 110(6):2027-2033
Doi: 10.1182/blood-2007-02-074203
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
- Leading authors Med Uni Graz
- Gattenlöhner Stefan
- Altmetrics:
- Dimensions Citations:
- Plum Analytics:
- Scite (citation analytics):
- Abstract:
- CD56(high) acute myeloid leukemias (AMLs) have a poor prognosis, but it has been unclear how CD56 expression is controlled and how it relates to clinical aggressiveness. We show that CD56 expression on AML cells correlates with an abnormal expression pattern of runt-related transcription factor 1 (RUNX1) isoforms. Whereas full-length p48 RUNX1 (p48) up-regulated CD56 in AML cells, 3 previously unknown shorter RUNX1 isoforms, p38a, p30, and p24, suppressed CD56 expression. Both p48 and CD56 induced nuclear translocation of nuclear factor (NF)-kappaB and increased bcl2L12 expression, and inhibition of this pathway by small inhibitory RNA-mediated p48 knock down or NF-kappaB blockade substantially increased apoptosis in CD56(+) AML cell lines. These findings indicate the potential for new therapy of CD56(high) AML by suppression of the "overactive" RUNX1/CD56/NF-kappaB signaling pathway(s).
- Find related publications in this database (using NLM MeSH Indexing)
- Acute Disease -
- Annexin A5 - metabolism
- Antigens, CD56 - chemistry Antigens, CD56 - genetics Antigens, CD56 - metabolism
- Apoptosis -
- Blotting, Western -
- Case-Control Studies -
- Cell Nucleus - genetics Cell Nucleus - metabolism
- Core Binding Factor Alpha 2 Subunit - genetics Core Binding Factor Alpha 2 Subunit - metabolism
- Cytosol - metabolism
- Gene Expression Regulation, Leukemic -
- Gene Library -
- Genes, Dominant -
- Humans -
- Immunoenzyme Techniques -
- Leukemia, Myeloid - metabolism Leukemia, Myeloid - pathology
- Luciferases - metabolism
- Muscle Proteins - genetics Muscle Proteins - metabolism
- NF-kappa B - antagonists and inhibitors NF-kappa B - genetics NF-kappa B - metabolism
- Protein Isoforms -
- Protein Transport -
- Proto-Oncogene Proteins c-bcl-2 - genetics Proto-Oncogene Proteins c-bcl-2 - metabolism
- RNA, Small Interfering - pharmacology
- Reverse Transcriptase Polymerase Chain Reaction -
- Ribonucleases -
- Tumor Cells, Cultured -